LifeClean International AB (DE:651)
FRANKFURT:651
651 Stock Chart & Stats
€0.01
>-€0.01(-1.25%)
At close: 4:00 PM EST
€0.01
>-€0.01(-1.25%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.07
Previous CloseN/A
Volume0.00
Average Volume (3M)2.00K
Market Cap
€4.39M
Enterprise Value€32.90M
Total Cash (Recent Filing)€2.14M
Total Debt (Recent Filing)€21.37M
Price to Earnings (P/E)―
Beta9.92
Next Earnings
Jul 15, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding1,025,575,800
10 Day Avg. Volume0
30 Day Avg. Volume2,000
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)7.74
Price to Sales (P/S)0.48
P/FCF Ratio-0.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)€12.49M
Bulls Say, Bears Say
Bulls Say
Proprietary Disinfection ProductsOwning proprietary chemistry and bundled implementation support creates product differentiation and higher switching costs in professional settings. This structural advantage can sustain customer relationships, enable premium pricing or service contracts, and support longer-term retention versus commodity suppliers.
Structural Infection-control DemandThe company's focus on healthcare and professional hygiene taps a secular market driven by regulatory standards and ongoing infection-control needs. Structural demand for sanitation solutions tends to persist across cycles, supporting a stable addressable market for product and service adoption over months to years.
Top-line Momentum (TTM Revenue +20%)Sustained revenue growth (~20% TTM) indicates market traction and expanding adoption of LifeClean's solutions. If maintained, topline growth can enable operating leverage, improve scale economics, and provide a pathway to margin recovery, making growth a durable driver of future financial improvement.
Bears Say
Negative Gross Profit & Deep LossesGross profit is negative and net margin is deeply negative (~-61% TTM), indicating the core unit economics are currently unprofitable. Persistent negative gross margins suggest structural pricing or cost issues that must be resolved before the business can sustainably reach positive operating earnings.
Persistent Cash BurnOperating and free cash flow are materially negative across periods, reflecting ongoing cash burn. Continued negative cash flow forces reliance on external financing, limits reinvestment capacity, and elevates execution risk if funding markets tighten over the coming months.
High Leverage And Thin EquityBalance-sheet fragility is evident with very high debt-to-equity and a thin or negative equity base in recent years. Elevated leverage reduces financial flexibility, increases refinancing and covenant risk, and raises the probability of dilutive capital raises if operating losses persist.
LifeClean International AB News
651 FAQ
What was LifeClean International AB’s price range in the past 12 months?
LifeClean International AB lowest stock price was <€0.01 and its highest was €0.07 in the past 12 months.
What is LifeClean International AB’s market cap?
LifeClean International AB’s market cap is €4.39M.
When is LifeClean International AB’s upcoming earnings report date?
LifeClean International AB’s upcoming earnings report date is Jul 15, 2026 which is in 33 days.
How were LifeClean International AB’s earnings last quarter?
LifeClean International AB released its earnings results on Apr 29, 2026. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.002.
Is LifeClean International AB overvalued?
According to Wall Street analysts LifeClean International AB’s price is currently Overvalued.
Does LifeClean International AB pay dividends?
LifeClean International AB does not currently pay dividends.
What is LifeClean International AB’s EPS estimate?
LifeClean International AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LifeClean International AB have?
LifeClean International AB has 1,025,575,800 shares outstanding.
What happened to LifeClean International AB’s price movement after its last earnings report?
LifeClean International AB reported an EPS of -€0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of LifeClean International AB?
Currently, no hedge funds are holding shares in DE:651
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
LifeClean International AB
LifeClean International AB (publ) is a Swedish company that engages in the comprehensive process of investigating, manufacturing, promoting, and distributing disinfection agents within Sweden. A key innovation from the company is its patented surface disinfectant. This powerful formula is engineered to eradicate a wide array of harmful microorganisms, including spores, fungi, tenacious biofilms, bacteria, and viruses. It is designed for versatile application across various equipment and surfaces, encompassing flooring, walls, furniture, and overhead structures. The enterprise was founded in 2012 and maintains its operational base in Uddevalla, Sweden.